Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans


Complex disorders such as diabetes, cardiovascular disease, asthma, hypertension and psychiatric illnesses account for a large and disproportionate share of health care costs, but remain poorly characterized with respect to aetiology. The transmission of such disorders is complex, reflecting the actions and interactions of multiple genetic and environmental factors. Genetic analyses that allow for the simultaneous consideration of susceptibility from multiple regions may improve the ability to map genes for complex disorders1,2, but such analyses are currently computationally intensive and narrowly focused. We describe here an approach to assessing the evidence for statistical interactions between unlinked regions that allows multipoint allele–sharing analysis to take the evidence for linkage at one region into account in assessing the evidence for linkage over the rest of the genome. Using this method, we show that the interaction of genes on chromosomes 2 (NIDDM1) and 15 (near CYP19) makes a contribution to susceptibility to type 2 diabetes in Mexican Americans from Starr County, Texas.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Interaction between NIDDM1 and CYP19.


  1. 1

    Schork, N.J., Boehnke, M., Terwilliger, J.D. & Ott, J. Two–trait–locus linkage analysis: a powerful strategy for mapping complex genetic traits. Am. J. Hum. Genet. 53, 1127–1136, 1993.

  2. 2

    Buhler, J., Owerbach, D., Schaffer, A.A., Kimmel, M. & Gabbay, K.H. Linkage analyses in type I diabetes mellitus using CASPAR, a software and statistical program for conditional analysis of polygenic diseases. Hum. Hered. 47, 211–222 (1997).

  3. 3

    Kruglyak, L., Daly, M.J., Reeve–Daly, M.P. & Lander, E.S. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am. J. Hum. Genet. 58, 1347–1363 (1996).

  4. 4

    MacLean, C.J., Sham, P.C. & Kendler, K.S. Joint linkage of multiple loci for a complex disorder. Am. J. Hum. Genet. 53, 353–366 (1993).

  5. 5

    Risch, N. Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am. J. Hum. Genet. 46, 229–241 (1990).

  6. 6

    Cordell, H.J., Todd, J.A., Bennett, S.T., Kawaguchi, Y. & Farrall, M. Two–locus maximum lod score analysis of a multifactorial trait: joint consideration of IDDM2 and IDDM4 with IDDM1 in type 1 diabetes. Am. J. Hum. Genet. 57, 920–932 (1995).

  7. 7

    Bonney, G.E. On the statistical determination of major gene mechanisms in continuous human traits. Am. J. Med. Genet. 18, 731–749 (1984).

  8. 8

    Kong, A. & Cox, N.J. Allele–sharing models: LOD scores and accurate linkage tests. Am. J. Hum. Genet. 61, 1179–1188 (1997).

  9. 9

    Hanis, C.L. et al. A genome–wide search for human non–insulin–dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nature Genet. 13, 161–166 (1996).

  10. 10

    Bell, G.I. et al. Genetics of NIDDM in the Mexican American of Starr County, Texas: an update. Diabetes Rev. 5, 277–283 (1997).

  11. 11

    Lander, E.S. & Kruglyak, L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nature Genet. 11, 241–247 (1995).

  12. 12

    Terauchi, Y. et al. Development of non–insulin–dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate–1 and β cell glucokinase genes. J. Clin. Invest. 99, 861–866 (1997).

  13. 13

    Brunning, J.C. et al. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS–1 null alleles. Cell 88, 561–572 (1997).

  14. 14

    Mahtani, M.M. et al. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nature Genet. 14, 90–94 (1996).

  15. 15

    Iwasaki, N. et al. Mutations in the hepatocyte nuclear factor–1α/MODY3 gene in Japanese subjects with early– and late–onset NIDDM. Diabetes 46, 1504–1508 (1997).

  16. 16

    Suarez, B.K., Hampe, C.L. & Van Eerdewegh, P. Problems of replicating linkage claims in psychiatry. in Genetic Approaches to Mental Disorders (eds Gershon, E.S. & Cloninger, C.R.) 23–46 (American Psychiatric Press, London, 1994).

  17. 17

    Froguel, P. et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N. Engl. J. Med. 328, 697–702 (1993).

  18. 18

    Yamagata, K. et al. Mutations in the hepatocyte nuclear factor–1α gene in maturity onset diabetes of the young (MODY3). Nature 384, 455–458 (1996).

  19. 19

    Horikawa, Y. et al. Mutation in hepatocyte nuclear factor–1β gene (TCF2) associated with MODY. Nature Genet. 17, 384–385 (1997).

  20. 20

    Yamagata, K. et al. Mutations in the hepatocyte nuclear factor–4α gene in maturity onset diabetes of the young (MODY1). Nature 384, 458–460 (1996).

  21. 21

    Stoffers, D.A., Ferrer, J., Clarke, W.L. & Habener, J.F. Early–onset type–II diabetes mellitus (MODY4) linked to IPF1. Nature Genet. 17, 138–139 (1997).

Download references


This research was supported in part by National Institutes of Health grants GM–46800, DK–20595, DK–47481, DK–47486, DK–47487 and DK–47494.

Author information

Correspondence to Nancy J. Cox.

Rights and permissions

Reprints and Permissions

About this article

Further reading